Fulgent Genetics, Inc.
El Monte, CA Part of Fulgent Therapeutics LLC
- UEI
- Y9JMAEN8GRK6
- CAGE
- 810T8
- Primary NAICS
- 621511 Medical Laboratories
- SAM.gov registration
- Expired
Company facts
- FY2025 rankings
- Self-certified in SAM.gov
- Entity structure
- Corporate Entity (Not Tax Exempt)
- Other NAICS codes in SAM.gov
- Corporate family
-
-
Parent
Fulgent Therapeutics LLC · El Monte, CA
JVZDRESJLD82
-
- Fulgent Therapeutics LLC · El Monte, CA JVZDRESJLD82
-
-
Parent
Fulgent Therapeutics LLC · El Monte, CA
JVZDRESJLD82
- SAM.gov registration date
- Physical address
- 4399 Santa Anita Ave, El Monte, CA 91731, USA
- Website
- fulgentgenetics.com
- Founded
- 2011
- Employees
- 251-1K
- Estimated annual revenue
- $50M-$100M
- Industry
-
- Industrials
- Commercial & Professional Services
- Professional Services
- SIC code
- 87 Engineering & Management Services
- Profiles
Registration and certifications come from SAM.gov and the SBA; company details from public web sources. Updated .
Contract obligations
Most of Fulgent Genetics, Inc.'s contract dollars go to its subsidiaries: $7.41 million across 2 awardees in NAICS 621511 in FY2025.
Contract awards
| Award | Agency | Obligated | Awarded |
|---|---|---|---|
| Genetic testing for VA portland health care system | Veterans Integrated Service Network 20 (VHA) | $133,800 |
Similar vendors
| Vendor | Location | Primary NAICS |
|---|---|---|
| Invitae Corporation | — | 621511 Medical Laboratories |
| Ailife Diagnostics, Inc. | Pearland, TX | 621511 Medical Laboratories |
| Baylor Miraca Genetics Laboratories LLC | Houston, TX | 621511 Medical Laboratories |
| Clear Labs Inc. | San Carlos, CA | 621511 Medical Laboratories |
| Tempus Labs, Inc. | — | 541714 Research and Development in Biotechnology (except Nanobiotechnology) |
About the company
Fulgent Genetics, Inc. is a for-profit corporate entity based in El Monte, California, specializing in advanced genetic testing, genomic sequencing, and diagnostic services. Registered in SAM.gov since January 2018, the company provides comprehensive genetic and molecular testing solutions primarily to federal agencies through its parent organization and subsidiary, Fulgent Therapeutics LLC. The company operates as a parent entity with a focus on delivering sophisticated genetic testing capabilities across various medical domains, including oncology, medical genetics, and pharmacogenomics.
The company has secured multiple federal contract awards primarily from the Department of Veterans Affairs (VA), Department of Health and Human Services (HHS), Centers for Disease Control and Prevention (CDC), and Department of the Army. These contracts encompass a wide range of genetic testing services, including germline genetic testing, next-generation DNA sequencing, clinical genetic testing for conditions like chronic kidney disease, anatomic pathology laboratory services, and specialized molecular testing. Notably, Fulgent Therapeutics has been awarded contracts for SARS-COV-2 genomic sequencing, genetic testing for various VA healthcare systems, and specialized testing services such as multi-gene panels, immunohistochemical staining, and solid tumor sequencing. None of these contracts were designated as set-aside, indicating Fulgent competed in open federal procurement processes.
Fulgent Genetics holds significant Indefinite Delivery Contract (IDC) and Blanket Purchase Agreement (BPA) vehicles with federal agencies. The most prominent is a $99,032,828.20 multiple-award IDC with the VA Strategic Acquisition Center-Frederick, providing national access to germline genetic testing through September 2029. This IDC includes task orders for germline pharmacogenomic molecular testing and supports VA's Oncology, Medical Genetics, and Pharmacogenomics programs. Additionally, the company secured a $500,000 multiple-award BPA with the Department of the Army Medical Center to provide comprehensive genetic testing services at Tripler Army Medical Center in Hawaii. These vehicles demonstrate Fulgent's capability to provide advanced genetic testing technologies across military and veteran healthcare systems, with contract scopes covering various medical specialties including cardiology, dermatology, and oncology.
Quick answers
Is Fulgent Genetics, Inc. registered in SAM.gov?
Fulgent Genetics, Inc.'s SAM.gov registration expired on September 3, 2026.
How does Fulgent Genetics, Inc. rank among federal contractors?
Fulgent Genetics, Inc. ranked #9 in NAICS 621511, #11 in NAICS 6215 and #11 in PSC Q3 in FY2025.
What is Fulgent Genetics, Inc.'s most recent federal award?
Fulgent Genetics, Inc.'s most recent federal contract award is Genetic testing for VA portland health care system (36C26024P0864), from Veterans Integrated Service Network 20 (VHA), on August 1, 2024.
On GovTribe
See Fulgent Genetics, Inc.'s full federal record
- Federal contract awards
- IDV awards
- Funding analysis by agency, NAICS and set-aside
- Similar vendors